Campbell Family Prc & Intrnl Med Asocs

CLIA Laboratory Citation Details

3
Total Citations
36
Total Deficiencyies
15
Unique D-Tags
CMS Certification Number 45D0700812
Address 10950 Resource Parkway Suite A, Houston, TX, 77089
City Houston
State TX
Zip Code77089
Phone(281) 484-5587

Citation History (3 surveys)

Survey - November 27, 2019

Survey Type: Standard

Survey Event ID: WULY11

Deficiency Tags: D0000 D5781 D5783 D5791 D0000 D5781 D5783 D5791

Summary:

Summary Statement of Deficiencies D0000 Noted deficiencies and plans of correction were discussed with the laboratory representative(s) at the exit conference. The facility representative(s) were given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. The facility was found to be in compliance with applicable Conditions of Participation in the CLIA program, and recertification is recommended. D5781

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - September 13, 2019

Survey Type: Special

Survey Event ID: KV9N11

Deficiency Tags: D0000 D0000 D2016 D2121 D2130 D6018 D2016 D2121 D2130 D6000 D6000 D6018

Summary:

Summary Statement of Deficiencies D0000 The following deficiencies are a result of a desk review of proficiency testing scores obtained from the CMS (Center for Medicare Services) national database and verified with the proficiency testing company, Oneworld Accuracy. The facility was found to be out of compliance with the conditions of participation of the CLIA program. The conditions not met were: D2016 - 42 C.F.R. 493.803 Condition: Successful participation [proficiency testing] D6000 - 42 C.F.R. 493.1403 Condition: Laboratories performing moderate complexity testing; laboratory director; D2016 SUCCESSFUL PARTICIPATION CFR(s): 493.803(a)(b)(c) (a) Each laboratory performing nonwaived testing must successfully participate in a proficiency testing program approved by CMS, if applicable, as described in subpart I of this part for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. (b) Except as specified in paragraph (c) of this section, if a laboratory fails to participate successfully in proficiency testing for a given specialty, subspecialty, analyte or test, as defined in this section, or fails to take remedial action when an individual fails gynecologic cytology, CMS imposes sanctions, as specified in subpart R of this part. (c) If a laboratory fails to perform successfully in a CMS- approved proficiency testing program, for the initial unsuccessful performance, CMS may direct the laboratory to undertake training of its personnel or to obtain technical assistance, or both, rather than imposing alternative or principle sanctions except when one or more of the following conditions exists: (1) There is immediate jeopardy to patient health and safety. (2) The laboratory fails to provide CMS or a CMS agent with satisfactory evidence that it has taken steps to correct the problem identified by the unsuccessful proficiency testing performance. (3) The laboratory has a poor compliance history. This CONDITION is not met as evidenced by: Based on a desk review of proficiency testing records obtained from the CMS (Center Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- for Medicare Services) national database and verified with the proficiency testing company, Oneword Accuracy, it was determined the laboratory had not successfully participated in a proficiency testing program approved by HHS, for each specialty, subspecialty, and analyte or test in which the laboratory is certified under CLIA. The laboratory did not successfully participate in the specialty of Hematology for the analyte Hemoglobin. ( refer to D2130) D2121 HEMATOLOGY CFR(s): 493.851(a) Failure to attain a score of at least 80 percent of acceptable responses for each analyte in each testing event is unsatisfactory analyte performance for the testing event. This STANDARD is not met as evidenced by: Based on a proficiency testing desk review of CMS form 155 and Oneworld accuracy records found that the laboratory failed to attain a score of at least 80% acceptable responses for each analyte in the subspecialty of hematology for the analyte Hemoglobin. Findings: 1. 2018 - 3rd event the laboratory received an unsatisfactory score of 60% for Hemoglobin. 2. 2019 - 2nd event the laboratory received an unsatisfactory score of 0% for Hemoglobin. Key: CMS- Centers for Medicare & Medicaid Services D2130 HEMATOLOGY CFR(s): 493.851(f) Failure to achieve satisfactory performance for the same analyte in two consecutive events or two out of three consecutive testing events is unsuccessful performance. This STANDARD is not met as evidenced by: Based on a proficiency testing desk review of CMS form 155 and Oneworld accuracy records, it was determined the laboratory failed to achieve satisfactory performance (80% or greater) for the same analyte in the specialty of hematology in two consecutive testing events or two out of three consecutive testing events. Two out of three unsatisfactory scores results in unsuccessful PT performance. Findings: 1. 2018 - 3rd event the laboratory received an unsatisfactory score of 60% for Hemoglobin. 2. 2019 - 2nd event the laboratory received an unsatisfactory score of 0% for Hemoglobin. Key: CMS- Centers for Medicare & Medicaid Services D6000 MODERATE COMPLEXITY LABORATORY DIRECTOR CFR(s): 493.1403 The laboratory must have a director who meets the qualification requirements of 493. 1405 of this subpart and provides overall management and direction in accordance with 493.1407 of this subpart. This CONDITION is not met as evidenced by: Based on a desk review of laboratory proficiency testing performance it was revealed that the laboratory director failed to provide overall management and direction of the laboratory services. Refer to D6016 -- 2 of 3 -- D6018 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1407(e)(4)(iii) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, and record and report test results promptly, accurate, and proficiently and for assuring compliance with the applicable regulations. (e) The laboratory director must-- (e)(4)(iii) Ensure that all proficiency testing reports received are reviewed by the appropriate staff to evaluate the laboratory's performance and to identify any problems that require

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - April 18, 2018

Survey Type: Standard

Survey Event ID: 7DXX11

Deficiency Tags: D5437 D5783 D5791 D6016 D6046 D6049 D6046 D6049 D6052 D0000 D2007 D5437 D5783 D5791 D6016 D6052

Summary:

Summary Statement of Deficiencies D0000 Noted deficiencies and plans of correction were discussed with the laboratory representative(s) at the exit conference. The facility representative(s) were given an opportunity to provide evidence of compliance with the noted deficiencies, and no such evidence was provided prior to survey exit. The facility was found to be in compliance with applicable Conditions of Participation in the CLIA program, and recertification is recommended. D2007 TESTING OF PROFICIENCY TESTING SAMPLES CFR(s): 493.801(b)(1) The samples must be examined or tested with the laboratory's regular patient workload by personnel who routinely perform the testing in the laboratory, using the laboratory's routine methods This STANDARD is not met as evidenced by: Based on review of the laboratory policy, review of the laboratory's One World Accuracy accutest proficiency testing records from 2017 and 2018, and confirmed in interview revealed the laboratory failed to have documentation of rotating proficiency testing among all testing personnel for hematology. Findings were: 1. Review of the laboratory General Policies (approved 05/01/1997) revealed under Proficiency Testing Procedure "All laboratory personnel who perform tests on patient specimens participate in PT testing." 2. A review of the laboratory's One World Accuracy accutest proficiency testing records from 2017 and 2018 revealed testing person #1 (TP#1) performed 4 of 4 testing events for hematology. 2017 Hematology 1st event 2017 Hematology 2nd event 2017 Hematology 3rd event 2018 Hematology 1st event 3. An interview with the MA (medical assistant) supervisor on 4/18/18 at 1030 hours in the office confirmed the above findings. She stated she only "trusted" TP#1 to perform the proficiency testing. D5437 CALIBRATION AND CALIBRATION VERIFICATION Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 5 -- CFR(s): 493.1255(a) Unless otherwise specified in this subpart, for each applicable test system the laboratory must perform and document calibration procedures-- (1) Following the manufacturer's test system instructions, using calibration materials provided or specified, and with at least the frequency recommended by the manufacturer; (2) Using the criteria verified or established by the laboratory as specified in 493.1253(b) (3)-- (2)(i) Using calibration materials appropriate for the test system and, if possible, traceable to a reference method or reference material of known value; and (2)(ii) Including the number, type, and concentration of calibration materials, as well as acceptable limits for and the frequency of calibration; and (3) Whenever calibration verification fails to meet the laboratory's acceptable limits for calibration verification. This STANDARD is not met as evidenced by: Based on review of the manufacturer's instructions, laboratory records, and confirmed in interview, the laboratory failed to follow the manufacturer's instructions to verify the precision prior to calibration for the Cell Dyn hematology analyzer. Findings were: 1. Review of the Cell-Dyn18 Plus Calibrator assay sheet (350008-3) revealed under instructions for use: "Verify instrument precision." 2. Review of the Pre- Calibration Procedure Checklist (Celly Dyn Emerald Operator's Manual 9140861C, December 2009) revealed "Verify the instrument precision by running a fresh, normal whole blood specimen ten times into PRECISION file...Ensure that CV% results are within the limits as provided in Section 4: Performance Characteristics and Specifications." "MCV %CV Limit 0.8%" 3. Review of the 2017 calibration data records revealed the precision was above the limit of 0.8% for 2 of 4 calibrations performed. 02/28/17 MCV - 1.7 10/26/17 MCV - 1.0 4. An interview with the testing person #1 on 04/18/18 at 1105 hours in the laboratory confirmed the above findings. She stated acknowledged that she doesn't verify the %limits when performing the calibration. D5783

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access